Free shipping on all orders over $ 500

Astressin 2B

Cat. No. M52789

All AbMole products are for research use only, cannot be used for human consumption.

Astressin 2B Structure
Size Price Availability Quantity
1mg USD 550 In stock
5mg USD 1400 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Astressin 2B is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively.

Chemical Information
Molecular Weight 4041.69
Formula C183H307N49O53
CAS Number 681260-70-8
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related CFTR Products
Ataluren

Ataluren (PTC124) is a novel, orally available small molecular CFTR-G542X nonsense allele inhibitor.

VX-770 (Ivacaftor)

VX-770 (Ivacaftor) is a first-in-class potentiator of CFTR, which targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM, respectively.

Lonidamine

Lonidamine (AF-1890) is a novel CFTR open channel blocker with an IC50 of 0.85 mM, which inhibits aerobic glycolysis in cancer cells. Lonidamine (AF-1890) is a hexokinase and mitochondrial pyruvate carrier inhibitor (Ki=2.5 μM).

VX-809

VX-809 is a CFTR corrector that improves CFTR processing and maturation in the cell.

CFTR(inh)-172

CFTR(inh)-172 is a voltage-independent, selective CFTR inhibitor with Ki of 300 nM, showing no effects on MDR1, ATP-sensitive K+ channels, or a series of other transporters.

  Catalog
Abmole Inhibitor Catalog




Keywords: Astressin 2B supplier, CFTR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.